Novogene Co Ltd
SSE:688315

Watchlist Manager
Novogene Co Ltd Logo
Novogene Co Ltd
SSE:688315
Watchlist
Price: 13.07 CNY 0.38% Market Closed
Market Cap: 5.3B CNY
Have any thoughts about
Novogene Co Ltd?
Write Note

Net Margin
Novogene Co Ltd

9%
Current
10%
Average
0.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9%
=
Net Income
182.9m
/
Revenue
2B

Net Margin Across Competitors

Country CN
Market Cap 5.4B CNY
Net Margin
9%
Country US
Market Cap 1.2T USD
Net Margin
9%
Country US
Market Cap 201.2B USD
Net Margin
14%
Country US
Market Cap 166.9B USD
Net Margin
18%
Country KR
Market Cap 66.5T KRW
Net Margin
24%
Country CH
Market Cap 38.8B CHF
Net Margin
9%
Country US
Market Cap 38.7B USD
Net Margin
20%
Country US
Market Cap 36.2B USD
Net Margin
9%
Country US
Market Cap 26.8B USD
Net Margin
21%
Country US
Market Cap 24.2B USD
Net Margin
17%
Country US
Market Cap 22.2B USD
Net Margin
21%
No Stocks Found

Novogene Co Ltd
Glance View

Market Cap
5.4B CNY
Industry
Life Sciences Tools & Services

Novogene Co., Ltd. engages in the provision of genomic services and solutions. The company is headquartered in Beijing, Beijing and currently employs 2,284 full-time employees. The company went IPO on 2021-04-13. The firm mainly relies on high-throughput sequencing technology and bioinformatics analysis technology to establish gene sequencing platforms. Combined with multi-omics research technology, the Company provides multi-level scientific and research technical services and solutions for life science basic research, medical and clinical application research. At the same time, based on the technology accumulation in gene sequencing and its application fields, the Company independently develops genetic testing medical equipment. The firm's services mainly include life science basic scientific research services, medical research and technical services, and database-building sequencing platform services. Its other services and products include gene mutation detection kits, coronavirus disease nucleic acid test service and DA8600 sequencers. The firm conducts its businesses in domestic and overseas markets.

Intrinsic Value
23.42 CNY
Undervaluation 44%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9%
=
Net Income
182.9m
/
Revenue
2B
What is the Net Margin of Novogene Co Ltd?

Based on Novogene Co Ltd's most recent financial statements, the company has Net Margin of 9%.